Achievements｜Department of Virology, Institute of Tropical Medicine, Nagasaki University

Presentations

2021-11-03

Khine Mya Nwe

Serological evidence of Zika virus infection in febrile patients and health blood donors in Sabah, Malaysian Borneo, 2017-2018.

Presentations

2021-11-03

Ngan Thi Thanh Nguyen

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

Presentations

2021-11-03

Mizuki Fukuta

Muzuki Fukuta has a presentation in The 62nd Annual Meeting for the Japanese Society of Tropical Medicine.

Presentations

2021-09-29

Thi Thanh Ngan Nguyen

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

Presentations

2021-09-29

Sandra Kendra Raini

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Presentations

2021-09-29

Elizabeth Ajema Chebichi Luvai,

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

Presentations

2021-09-11

Jean Claude Balingit

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Presentations

2021-09-11

Mizuki Fukuta

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Presentations

2021-09-11

Mya Myat Ngwe Tun

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

Presentations

2021-05-24

Jean Claude Balingit

Paper

Serological evidence of Zika virus infection in febrile patients and health blood donors in Sabah, Malaysian Borneo, 2017-2018.

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

Muzuki Fukuta has a presentation in The 62nd Annual Meeting for the Japanese Society of Tropical Medicine.

Pre-existing neutralizing activity to SARS-CoV-2 in Vietnam prior to COVID-19 pandemic, 2014-2019.

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.

Evidence of Chikungunya virus seroprevalence in Myanmar among Dengue suspected patients and healthy volunteers in the years 2013, 2015 and 2018.

A simple and high-throughput alternative virus assay in the serologic diagnosis of mosquito-borne flavivirus infections.

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.